Argenx
ARGX
#571
Rank
ยฃ28.79 B
Marketcap
ยฃ481.47
Share price
1.54%
Change (1 day)
21.96%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of June 2024 : ยฃ26.98 Million

According to Argenx 's latest financial reports the company's total debt is ยฃ26.98 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2022-12-31ยฃ10.27 M20.93%
2021-12-31ยฃ8.49 M-2.53%
2020-12-31ยฃ8.71 M39.37%
2019-12-31ยฃ6.25 M
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31ยฃ1.83 M-0.05%
2011-12-31ยฃ1.83 M